- Previous Close
0.0650 - Open
0.0600 - Bid 0.0600 x --
- Ask 0.0700 x --
- Day's Range
0.0600 - 0.0600 - 52 Week Range
0.0200 - 0.1400 - Volume
182,000 - Avg. Volume
320,173 - Market Cap (intraday)
9.08M - Beta (5Y Monthly) 1.93
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products. The company engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based Capsules, and market-ready products. The company exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K and iron. It engages in the business of secondary processing of ingredients to produce micellized materials from certain vitamins, nutraceuticals, and cannabis extracts that makes fat-soluble substances available for immediate absorption into the body reach near 100% bioavailability and water compatibility. The company provides its products under MOD and .decimal brands. Glow Lifetech Corp. was founded in 1988 and is headquartered in Toronto, Canada.
glowlifetech.comRecent News: GLOW.CN
View MorePerformance Overview: GLOW.CN
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GLOW.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GLOW.CN
View MoreValuation Measures
Market Cap
9.08M
Enterprise Value
8.54M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.48
Price/Book (mrq)
13.51
Enterprise Value/Revenue
15.41
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-258.65%
Return on Assets (ttm)
-34.78%
Return on Equity (ttm)
-418.85%
Revenue (ttm)
554.47k
Net Income Avi to Common (ttm)
-1.43M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
884.35k
Total Debt/Equity (mrq)
210.91%
Levered Free Cash Flow (ttm)
-665.68k